LifeStance Health reported a solid start to 2025, exceeding guided metrics and achieving positive net income for the first time. The company showed strong clinician growth, improved operational efficiencies, and a significant improvement in free cash flow. However, pressures on revenue per visit and the competitive environment for recruiting clinicians present challenges. Overall, the positive aspects of the earnings call outweigh the negatives, indicating a strong performance and outlook.

Company Guidance -

Q3 2025

In the first quarter of 2025, LifeStance Health surpassed its financial guidance, reporting a robust performance across several metrics. They achieved a double-digit adjusted EBITDA margin of 10.4%, marking an improvement over expectations, and recorded positive net income for the first time since becoming a public company. The company also reported a solid revenue growth of 11% year-over-year, reaching $333 million, driven by a 10% increase in visit volumes to 2.1 million, primarily due to a 10% growth in their clinician base, now totaling 7,535 clinicians. Total revenue per visit rose by 1% to $159. Furthermore, LifeStance improved its free cash flow by $17 million compared to the same period last year, although it was still negative $10 million. They maintained strong leverage ratios with net leverage at 1.2x and gross leverage at 2.3x, significantly improved from the prior year's figures. Looking ahead, they are confident in their full-year guidance ranges, expecting revenues of $1.4 billion to $1.44 billion, center margin between $440 million to $464 million, and adjusted EBITDA ranging from $130 million to $150 million.

Exceeded Guided Metrics

LifeStance Health exceeded each of its guided metrics for the first quarter of 2025, instilling confidence in their ability to deliver on full-year guidance.

Solid Financial Performance

Reported revenue of $333 million, representing an 11% year-over-year growth, with double-digit adjusted EBITDA margins of 10.4%.

Positive Net Income

Achieved positive net income for the first time in LifeStance's history as a public company, with net income of $700,000.

Clinician Growth

Increased clinician base by 152 clinicians or 10% year-over-year, bringing the total to 7,535 clinicians.

Operational Excellence

Completed the rollout of the digital patient check-in tool, driving higher patient satisfaction, operational efficiencies, and significant improvements in patient collections.

Strong Free Cash Flow Improvement

Improved free cash flow by $17 million year-over-year in the first quarter, despite being negative $10 million.

Lifestance Health Group (LFST) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LFST Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	>-0.01 / -	-0.02	―	―	―
Aug 07, 2025	2025 (Q2)	-0.02 / -0.01	-0.06	83.33% (+0.05)
May 07, 2025	2025 (Q1)	-0.03 / 0.00	-0.06	―
Feb 27, 2025	2024 (Q4)	-0.04 / -0.01	-0.12	91.67% (+0.11)
Nov 07, 2024	2024 (Q3)	-0.07 / -0.02	-0.17	88.24% (+0.15)
Aug 08, 2024	2024 (Q2)	-0.07 / -0.06	-0.13	53.85% (+0.07)
May 09, 2024	2024 (Q1)	-0.08 / -0.06	-0.09	33.33% (+0.03)
Feb 28, 2024	2023 (Q4)	-0.09 / -0.12	-0.13	7.69% (+0.01)
Nov 08, 2023	2023 (Q3)	-0.07 / -0.17	-0.11	-54.55% (-0.06)
Aug 09, 2023	2023 (Q2)	-0.08 / -0.13	-0.19	31.58% (+0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LFST Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$3.90	$3.86	-1.03%
May 07, 2025	$6.55	$5.51	-15.88%
Feb 27, 2025	$7.51	$7.74	+3.06%
Nov 07, 2024	$7.13	$7.68	+7.71%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lifestance Health Group (LFST) report earnings?

Lifestance Health Group (LFST) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Lifestance Health Group (LFST) earnings time?

Lifestance Health Group (LFST) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LFST EPS forecast?

LFST EPS forecast for the fiscal quarter 2025 (Q3) is >-0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing